Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL797237 | 0.93 | NQO1 (0.46) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| SCHEMBL29360084 | 0.90 | CYP1A2 (0.56) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| SCHEMBL119090 | 0.90 | CYP1A2 (0.56) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL27879112 | 0.87 | CYP1A2 (0.54) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL28178967 | 0.87 | CYP1A2 (0.54) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| Hydrogen Sulfide SCHEMBL27306888 | 0.87 | CYP1A2 (0.54) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| SCHEMBL6885497 | 0.87 | CYP1A2 (0.63) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| SCHEMBL4646013 | 0.83 | HSD17B10 (0.50) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| SCHEMBL28999606 | 0.83 | CYP1A2 (0.58) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 | |
| SCHEMBL29853748 | 0.83 | CYP1A2 (0.58) | CYP1A2CYP2A6TSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148541-A1 | AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2020-05-14 | — | — | US | disclosed |
| EP-1481428-A1 | ORGANIC THIN FILM TRANSISTOR WITH MODIFIED SURFACE OF GATE-DIELECTRIC | 3M Innovative Properties Company (US) | 2004-12-01 | — | — | EP | disclosed |
| US-6768132-B2 | MULTILAYER INTEGRATED CIRCUIT; BARRIER DIELECTRIC AND SEMICONDUCTOR | 3M INNOVATIVE PROPERTIES COMPANY | 2004-07-27 | — | — | US | disclosed |
| US-20030175551-A1 | Surface modified organic thin film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-09-18 | — | — | US | disclosed |
| WO-2003077327-A1 | ORGANIC THIN FILM TRANSISTORS WITH MODIFIED SURFACE OF GATE-DIELECTRIC | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148541-A1 | AN APPROACH TO A BOTTOM-UP SYNTHESIS OF NANOCARBONS | TYMS, NCL, PFAS | CYP1A2 711/4885CYP2A6 1259/4885TSHR 4781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.